TVGN - Tevogen Bio Holdings Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.7 0.04 (5.88%) --- --- 0.0 (0.0%) 0.0 (0.0%) 0.05 (7.13%) -0.02 (-2.57%) -0.02 (-2.57%)

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.03
Diluted EPS:
-0.03
Basic P/E:
-24.6833
Diluted P/E:
-24.6833
RSI(14) 1m:
100.0
VWAP:
0.74
RVol:

Events

Period Kind Movement Occurred At

Related News